The term “He’s The Man,” gets through around a lot and it is always in a positive manner. It shows that someone is in firm control of what they are doing and they control their lives. Bob Reina is the man over at Talk Fusion as the CEO and founder. He founded the company back in 2007 with a clear goal and clear mission: change lives. That is a big goal, but you have to dream big in today’s world. No one should settle for anything less than the best. It is the Bob Reina way and it is the Talk Fusion way. They are known as the best in the business at video technology. It is why they have won awards and afforded people the opportunity to work from home.
For so many people all over the world, that is the dream for them. They want to wok from home. They have a great idea and they want to see this idea put into motion. However, many of them are missing the tools to make it happen. Bob Reina is offering the tools, the guideline, and everything for the customer. He believes in them and he knows they can do something great with their careers. They are capable of anything they set their mind to in this day and age.
People have to understand that these are people that have been beaten down by the 9-5-job situation. They have had enough of it and they are sick and tired of it. They are worn out from it. It has made them miserable and they want out sooner rather than later. After all, you truly can’t put a price tag on happiness. However, Bob Reina is going to make sure people are happy using Talk Fusion. He is also going to use his position as CEO and founder for something positive.
Nothing is going to stop him or stand in his way. One of the greatest things he did was make a record-shattering donation to the Tampa Bay Humane Society. It was said to have saved countless animal lives. Learn more: http://inspirery.com/bob-reina/
Technology has revolutionized the operations of different industries, including the health sector. Horizon Internal Medicine is one of the hospitals that have adopted new technologies in medical practice such as robotic-guided surgeries. They perform robotic-aided cosmetic surgeries, which involves a small 3D camera that is placed in a patient’s body through a small incision. Surgeons guide the entire process by moving their hands. According to Dr. Imran Haque, robotic-guided surgeries are accurate since surgeons have a perfect view of the area through the monitor. There is minimal damage to the skin since only miniature incisions are made hence reduced probability for infection. Minimal openings also reduce recovery time and scaring.
Dr. Imran Haque practices medicine in North Carolina. His specializes in cosmetic surgery, weight management, laser hair removal, Venus-body contouring and diabetes management. With an experience of 15 years, Imran Haque has not only exhibited unmatched professionalism in his practice, but also a deep passion and commitment to assist patients. Imran practices internal medicine in leading hospitals like South Eastern Medical Hospital, High Point Regional Hospital, and Randolph Hospital. He also performs robotic-aided surgery. With his instruments, Dr. Imran Haque focuses on precision and versatility while performing operations like growth removal or augmentation.
Over the years, he has concerted his efforts in helping patients diagnosed with diabetes to manage the disease. In the United States, over 9.3 percent of the population is diabetic. The disease is characterized by the body’s failure to produce or respond to insulin hormone. The risk factors of diabetes include obesity, genetics and age-advancement. According to studies, family backgrounds can also be a risk factor. Diabetes exposes a patient to infected sores, blood pressure, kidney damage, nerve damage and increased cholesterol levels. However, managing diabetes is not difficult. Lifestyle routines like exercise, drinking more water, increasing fiber consumption and adopting healthy eating habits can help a patient to manage diabetes. Imran Haque focuses on ensuring that his patients overcome the disease.
Have you ever found yourself in a situation where you are talking to people and you feel like they don’t understand? You might explain it as best as you can and go into as much detail as possible, but they still don’t understand. For example, a lot of people hate their jobs with a fiery passion. They really, really hate it. They have reached the point where they are not sure how much more they can take and how they are going to handle another day. However, other people tell them, “Everyone hates their job. You just have to deal with it. Don’t let it get to you.” All of those things are much easier said than done. Learn more: http://inspirery.com/bob-reina/
Bob Reina is the person who will listen to someone, understand him or her, and come up with a way to make it better. While it is healthy to vent and it can feel good in the moment, in the end, it does not solve a single thing. Bob Reina is about solving people’s unhappiness the best way he knows how and that is with his company Talk Fusion, the absolute best in talk, voice, data, and chat. They have two awards from 2016 to back it up and prove it. They are now entering the decade mark, and they just keep getting better with age.
They are in the brainstorming room, 24/7, and they are looking at ways to advance the company and more importantly, advance the product. They want the product to stay on top and just keep improving as each day goes by without any issues. They take pride in the work they do as a company. Because of this, people are seeing their unhappiness go away. After a little bit of time, they are able to quit their job, start up their own business, and see it turn a very good profit.
As a matter of fact, they are making more money at their new job than they ever made at their old job. They are happier and they have more money. That is true happiness from a job perspective.
JeanMarie Guenot is the manager of the well-known Amphivena Therapeutics. She trained in physical and medicinal chemistry, majoring in quantum mechanical and semi-empirical methods for molecular dynamics, X-ray and NMR refinement, protein structure prediction, and drug design. She got her MBA from Wharton School, University of Pennsylvania and a Ph. D. from the University of California. Guenot boasts over 20 years’ experience in pharmaceutical and biotechnology industry. She founded and managed the SKS Ocular. She also served as the co-head of Corporate & Business Development unit at PDL BioPharma, according to her website: http://jeanmarieguenot.com/
Guenot’s fruitful scientific career commenced at Hoffman-La Roche, where she worked as the principal scientist in Preclinical R&D. Her responsibility was to develop drugs for metabolic & autoimmune diseases, inflammation, and oncology. Guenot’s business career, on the other hand, can be traced back at Atlas Ventures, where she managed venture capital investments. JeanMarie Guenot also served as the Hoffman-La Roche business adviser in Basel and Shanghai China between 2008 and 2009. In 2005, the Bio Business Network honored her with the BioBusiness Network Innovative Bio-Partnering Award. A year later, she received a deal of distinction from the Licensing Executives Society.
Amphivena Therapeutics Inc. is a company based in San Francisco that specializes in developing bi-functional antibody remedies for hematologic malignancies. The company is currently developing an innovative antibody therapy aimed at eradicating blood cancer. In a Series A financing led by MPM Capital, Amphivena Therapeutics garnered over $14 Million in July 2013. In 2015, the company hit yet another milestone by selecting a clinical candidate for further development in hematologic malignancies against an undisclosed tumor.
Contribution to Society
Through her inventions, JeanMarie Guenot has immensely impacted on the lives of many people. She has discovered drugs that cure inflammation and autoimmune diseases. She has led the fight against diseases like cancer through her commitment to research and drug development.
Presence on social media
Most of JeanMarie’s Facebook and Twitter posts are about her discoveries. Case in point, she tweeted about AMV564, a drug she recently discovered that could serve as a treatment for myeloid Leukemia.